Get the Stockscreener App
10.03
0.05%
0.005
Drugs Made In America Acquisition Corp stock is traded at $10.03, with a volume of 78,802.
It is up +0.05% in the last 24 hours and up +0.00% over the past month.
Drugs Made In America Acquisition Corp is a blank check company.
See More
Previous Close:
$10.03
Open:
$10.01
24h Volume:
78,802
Relative Volume:
0.39
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.10%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$10.01
$10.04
1-Week Range:
$10.01
$10.04
52-Week Range:
$10.00
$10.04
Drugs Made In America Acquisition Corp Stock (DMAAU) Company Profile
Name
Drugs Made In America Acquisition Corp
Sector
Industry
Phone
-
Address
-
Compare DMAAU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DMAAU
Drugs Made In America Acquisition Corp
|
10.03 | 0 | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
7.38 | 2.13B | 3.13B | 50.80M | 555.00M | 0.1772 |
|
AACT
Ares Acquisition Corporation Ii
|
11.02 | 688.75M | 0 | 16.92M | -1.35M | 0.29 |
|
BZAI
Blaize Holdings Inc
|
5.30 | 538.42M | 0 | 0 | 0 | 0.00 |
|
ANSC
Agriculture Natural Solutions Acquisition Corp
|
10.52 | 453.68M | 0 | 1.30M | 0 | 0.0301 |
|
EQV
Eqv Ventures Acquisition Corp
|
10.02 | 446.62M | 0 | 0 | 0 | 0.00 |
Drugs Made In America Acquisition Corp Stock (DMAAU) Latest News
Our History - Baxter
IPO NewsUS IPO Weekly Recap: Active January closes out with several sizable IPOs - Renaissance Capital
Sellas Life Sciences Group Announces $25 Million Registered Direct Offering - Defense World
Allogene Therapeutics, Inc. Announces Departure of Timothy MooreOn January 23, 2025, Allogene Therapeutics, Inc. (NASDAQ: ALLO) revealed in an 8-K filing that Timothy Moore, the Company’s incumbent executive, would be concluding his tenure with the - Defense World
OS Therapies Agrees to Acquire All Listeria Monotygenes-based Immuno-Oncology Programs and IP Assets from Ayala Pharmaceuticals: MarketBeat News - Defense World
Frontier Group Holdings Makes Proposal to Spirit Airlines for Potential Business Combination - Defense World
Winmark Corporation (NASDAQ: WINA) Approves Quarterly Cash Dividend - Defense World
BeyondSpring Inc. Enters into Preferred Share Purchase Agreement with SEED Therapeutics Inc. - Defense World
Drugs Made In America Acquisition Corp. (NASDAQ: DMAAU) Successfully Completes $200 Million IPOFort Lauderdale, FL, Jan. 29, 2025 – Drugs Made In America Acquisition Corp. (NASDAQ: DMAAU) recently announced the successful closure of its initial - Defense World
AITX’s RAD Secures Multiple RIO 360 Orders for New Municipal Client - Defense World
Juniper Networks Faces Legal Challenge with U.S. Department of Justice Seeking to Block Merger**On January 30, 2025, Juniper Networks, Inc. (NYSE: JNPR) encountered a significant hurdle as the U.S. Department of Justice filed a complaint in the Uni - Defense World
Boeing Reports Fourth Quarter ResultsARLINGTON, Va., January 28, 2025 – Boeing (NYSE: BA) has released its fourth quarter financial results for 2024, showcasing a revenue of $15.2 billion. The company reported a GAAP loss per share of ($5.46) and a c - Defense World
Adient Reports Financial Results for the Three Months Ended December 31, 2024Adient plc (NYSE: ADNT) recently released its condensed consolidated financial statements for the three months ending December 31, 2024. The company reported net sales of - Defense World
Hanover Bancorp, Inc. Announces Strong Fourth Quarter and Full Year 2024 Financial Results**WASHINGTON, D.C. – Hanover Bancorp, Inc. (NASDAQ: HNVR) reported its financial results for the fourth quarter and full year ended December 31, 2024, showc - Defense World
Barclays Lowers StoneCo (NASDAQ:STNE) Price Target to $10.00 - Defense World
Third Coast Bancshares (NASDAQ:TCBX) Stock Rating Lowered by Keefe, Bruyette & Woods - Defense World
SoFi Technologies (NASDAQ:SOFI) Price Target Raised to $20.00 - Defense World
SoFi Technologies (NASDAQ:SOFI) Price Target Raised to $14.00 - Defense World
Q1 Earnings Estimate for Hope Bancorp Issued By DA Davidson - Defense World
Drugs Made In America Acquisition Corp. Announces Closing of $200,000,000 Initial Public Offering - The Manila Times
DMAAUDrugs Made In America Acquisition Corp. Units Latest Stock News & Market Updates - StockTitan
Drugs Made In America SPAC Nets $200M To Buy Pharma Biz - Law360
FG Merger II Corp. (FGMCU) Prices $80M IPO - SPACInsider
Drugs Made In America Acquisition Prices $200 Million IPO -January 28, 2025 at 04:53 am EST - Marketscreener.com
Drugs Made In America Acquisition Corp. Announces Pricing of $200,000,000 Initial Public Offering - The Manila Times
New Pharma SPAC Launches With $200M War Chest: Inside The Latest Healthcare IPO - StockTitan
Full Stock Market News from 2025-01-27 - StockTitan
Layoff Tracker: Biogen to Cut Undisclosed Number of Research Employees - BioSpace
Danone’s yogurt sales surge among US consumers using GLP-1 drugs - Food Dive
Special Purpose Acquisition Company (SPAC) News and Analysis - SPACInsider
The top 10 biopharma M&A deals of 2024 - FiercePharma
Eli Lilly in advanced talks to buy US cancer biotech for up to $2.5bn - Financial Times
Trump’s Denmark Tariff Threat Means New Uncertainty for Ozempic Drugmaker Novo Nordisk - Barron's
2024 drug approvals: Small companies loom large with several key FDA nods - FiercePharma
Bright Green enters into restructuring security agreement with Lynn Stockwell - Yahoo Finance
LYNN STOCKWELL ENTERS INTO A RESTRUCTURING SECURITY - GlobeNewswire
Bright Green (BGXX) Announces Major Restructuring: Founder Returns as CEO, Plans API Manufacturing Focus - StockTitan
Novo Holdings' $16.5 bln Catalent buy wins EU antitrust approval - Reuters
On an investment spree, Lilly will spend $3B to expand newly acquired injectables plant in Wisconsin - FiercePharma
7 Companies Owned by Pfizer - Investopedia
Recursion Completes Exscientia Merger, Creates AI Drug Discovery Powerhouse with $20B+ Pipeline - StockTitan
Vivek Ramaswamy's Net Worth: How Harvard-Yale graduate became rich by selling 'sick' pharma companies - The Economic Times
Inside CVS and Walgreens' downturn: How misguided M&A damaged America's drugstores - Fortune
Top 10 Asthma Drug Companies | Provides Best MedicinesMarket.us Media - Market.us Media - United States Market News
FTC’s watchdog role in pharma mergers: Road bumps and the way forward - Norton Rose Fulbright
Novo Holdings' $16.5B Catalent buyout in crosshairs as consumer groups ask FTC to block the deal - FiercePharma
IPO Roundup: Drugs Made in America Acquisition, FBS Global and more (NYSEARCA:IPO) - Seeking Alpha
BeiGene launches PD-1 drug Tevimbra at 10% discount to Merck's Keytruda - FiercePharma
23andMe Is Sinking Fast. Can the Company Survive? - WIRED
Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements - GlobeNewswire
WuXi Waylaid - The Wire
Drugs Made In America Acquisition Corp Stock (DMAAU) Financials Data
There is no financial data for Drugs Made In America Acquisition Corp (DMAAU). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.59%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):